Disease awareness boosts Japan’s KRAS oncogene test market | Healthcare Asia Magazine
, Japan

Disease awareness boosts Japan’s KRAS oncogene test market

Nucleic acid amplification tests dominate the market.

The Kirsten rat sarcoma (KRAS) market in Japan is expected to grow at a compound annual growth rate of 12.5% between 2020 and 2025, driven by the growing incidence of colorectal and lung cancers, disease awareness, and technological advancements in diagnosis, according to GlobalData.

In particular, nucleic acid amplification test (NAAT) is majorly used in colorectal cancer (CRC) patients to detect gene mutation, which accounts for about 75% of the market in 2020, said GlobalData’s Medical Devices Analyst Aakriti R.

However, the Japanese Society of Medical Oncology has now pushed for KRAS testing for CRC patients because of its positive clinical results, Aakriti added.

Meanwhile, next-generation sequencing testing accounted for about 15% of the market, but is expected to grow because of its ability to detect rare and novel KRAS mutations.

“It is possible that a higher proportion of patients will be classified as having mutant KRAS and resistance to anti-EGFR therapies. GlobalData predicts the use of less sensitive methods... to decrease during the forecast period while NAATs will remain prevalent,” Aakriti said.

Follow the link for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!


CHI accelerates the development and adoption of health tech firm innovations
The Centre for Healthcare Innovation invests $2.4m (US1.8m) to set a framework that can test the safety of market-ready innovations.
Catholic Medical Center trailblazing big data and AI adoption in Korean healthcare
Its flagship Seoul St. Mary’s Hospital leads the seamless integration of cutting-edge technology across CMC’s eight affiliate hospitals.
OUE Healthcare poised to capture foreign patient demand for specialist care services
The healthcare group recently partnered with three medical specialist groups including two leading respiratory and cardiothoracic surgery specialist practices.
iClaim boosts Thailand’s health insurance claims in 10 seconds
IT expert Piyawat Maneenual sets up a game-changing platform that allows data transfer from hospitals to insurance companies in real-time.